Related Experiment Videos
Combination therapy: appropriate for everyone?
George Bensch1, Bruce M Prenner
1Allergy, Immunology, and Asthma Medical Group, Inc., Stockton, California, USA.
Summary
Asthma management requires flexible dosing of inhaled corticosteroids and bronchodilators. Combination inhalers may reduce treatment flexibility, impacting long-term asthma control.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Asthma severity fluctuates, necessitating adjustments in controller medication dosages.
- Current NIH guidelines recommend a step-care approach for asthma management.
- New combination inhalers (inhaled corticosteroid + long-acting bronchodilator) present challenges to this approach.
Purpose of the Study:
- To evaluate the advantages and disadvantages of combination inhalers for asthma management.
- To discuss the implications of fixed-dose combination products within the NIH step-care framework.
- To inform physician decision-making regarding asthma therapeutics.
Main Methods:
- Review of current NIH asthma management guidelines.
- Analysis of the impact of combination inhaler formulations on treatment flexibility.
- Discussion of recent literature on add-on controller medications for asthma.
Main Results:
- Combination inhalers offer convenience but may limit dose titration flexibility.
- Concerns exist regarding long-acting beta-agonists potentially masking inflammation and reducing rescue inhaler effectiveness.
- The fixed-dose nature of combination products challenges individualized asthma management.
Conclusions:
- Physicians must weigh the convenience of combination inhalers against the need for flexible asthma management.
- Careful consideration is needed to ensure optimal asthma control with new combination formulations.
- Further research may be needed to refine the step-care approach for combination inhaler use.